New Genetically Determined Markers of the Functional State of the Cardiovascular System

Genes (Basel). 2023 Jan 10;14(1):185. doi: 10.3390/genes14010185.

Abstract

Nowadays, cardiovascular diseases (CVDs) occupy a leading position in population mortality. Since it is known that the development of cardiovascular pathologies is determined mainly by the human genetic burden, an urgent task of primary prevention of CVDs is to assess the contribution of gene polymorphism to the formation of cardiovascular risk. The material for the study was the blood of volunteers aged 21 to 102 years. Polymorphisms were determined by real-time PCR. Multichannel volumetric sphygmography was performed to analyze the functional state of the vascular wall. The study revealed that the rs5742904 polymorphism of the ApoB gene was found to be absent in the studied groups of long-livers and descendants of long-livers. Results indicated that the carriage of the heterozygous variant of the MMP9 polymorphism is associated with a favorable prognosis for cardiovascular system functioning. A tendency towards an increase in the rate of biological age acceleration among subgroups with AA and GG genotypes of the MMP9 gene and a negative value of biological age acceleration among heterozygous carriers of this polymorphism allele were found. The conducted studies make it possible to identify new associations of the studied polymorphisms with the functional state of the cardiovascular system, which is of great clinical importance and requires further study.

Keywords: apolipoprotein B; cardiovascular disease; matrix metalloproteinases; methylenetetrahydrofolate reductase; single nucleotide polymorphism; sphygmography; type 1 collagen; vascular wall.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiovascular Diseases* / genetics
  • Cardiovascular System*
  • Genotype
  • Humans
  • Matrix Metalloproteinase 9 / genetics
  • Polymorphism, Genetic

Substances

  • Matrix Metalloproteinase 9

Grants and funding

The work was supported by the federal academic leadership program Priority 2030 (H-470-99).